Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE — Stella

Recruiting

Back to Meningioma trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

New York-Presbyterian/Weill Cornell Medical Center, New York, New York

Key details

Phase

Post-approval study

Sponsor

Weill Medical College of Cornell University

Collaborators

Curium US LLC

Enrollment target

~20 participants

Started

September 2024

Primary completion

January 2027

Age range

18 Years – 99 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov